外泌体诊断与治疗全球市场报告 2025

预计未来几年外泌体诊断和治疗市场规模将呈指数级增长。到 2029 年，这一数字将成长至 16.3 亿美元，复合年增长率为 28.0%。预测期内的成长可归因于不断扩大的临床应用、与数位健康技术的整合、支持性法规环境、基因编辑和 RNA 疗法以及免疫肿瘤学中不断扩大的作用。预测期内的关键趋势包括基于外泌体的药物发现、仿生外泌体工程、外泌体产品的商业化、外泌体装载的治疗货物以及用于癌症筛检的液态切片。

外泌体诊断和治疗市场的预期成长主要受到慢性病盛行率上升的强烈推动。慢性病是一种病程超过三个月并且随着时间推移病情会逐渐恶化的疾病，是全世界的主要健康问题。外泌体既可用于诊断，也可用于治疗，已成为癌症中很有前途的生物标记物，可实现更灵敏的疾病监测并促进获得个人化医疗。根据美国国家生物技术资讯中心（NCBI）2023年1月发布的预测，到2050年，全球罹患慢性病的人数将达到1.4266亿。这项统计数据凸显了慢性病盛行率的上昇在推动外泌体诊断和治疗市场发展方面发挥的关键作用。

老年人口的不断增长进一步加速了外泌体诊断和治疗市场的成长轨迹。 「老年人口」是指65岁以上的人口。这个不断增长的人口结构极大地促进了对外泌体诊断和治疗的需求，因为外泌体可以成为诊断和对抗与老龄化相关的疾病的有效工具。根据世界卫生组织（WHO）2022年10月发布的报告，到2030年，预计全球整体六分之一的人口将超过60岁，显示人口结构正在发生重大变化。预计到2050年，全球60岁或以上人口将达21亿人。这一人口变化凸显出老年人口的增加将对外泌体诊断和治疗市场的成长产生重大影响。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球外泌体诊断与治疗PESTEL分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
• 最终用途产业分析
• 全球外泌体诊断与治疗市场：成长率分析
• 全球外泌体诊断与治疗市场表现：规模与成长，2019 年至 2024 年
• 全球外泌体诊断与治疗市场预测：规模与成长，2024-2029 年，2034 年预测
• 全球外泌体诊断与治疗总目标市场 (TAM)

第六章 市场细分

• 全球外泌体诊断与治疗市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 装置
• 软体
• 试剂和套件
• 全球外泌体诊断与治疗市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 诊断
• 治疗
• 全球外泌体诊断与治疗市场：依最终使用者、绩效与预测，2019-2024 年、2024-2029 年、2034 年
• 学术研究所
• 製药和生物技术公司
• 医院和诊所
• 其他最终用户
• 全球外泌体诊断和治疗市场，仪器细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 外泌体分离系统
• 特性分析设备
• 分析设备
• 全球外泌体诊断和治疗市场，软体细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 资料分析软体
• 外泌体分析软体
• 实验室管理软体
• 全球外泌体诊断和治疗市场，按试剂和套件类型细分，性能和预测，2019-2024 年，2024-2029 年，2034 年
• 隔离套件
• 表征试剂
• 检测试剂套件

第七章 区域和国家分析

• 全球外泌体诊断与治疗市场：按地区、表现和预测，2019-2024 年、2024-2029 年、2034 年
• 全球外泌体诊断与治疗市场：按国家、表现和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 外泌体诊断与治疗市场：竞争格局
• 外泌体诊断与治疗市场：公司简介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• BioVision Inc.
• System Biosciences LLC
• Evox Therapeutics Ltd.
• ExCoBio Inc.
• BioCat GmbH
• NanoSomix Inc.
• Exosome Diagnostics Inc.
• Capricor Therapeutics Inc.
• Aethlon Medical Inc.
• Codiak BioSciences Inc.
• NX Pharmagen Inc.
• Exiqon A/S
• Aegle Therapeutics Corporation
• AMS Biotechnology Ltd.
• Cell Guidance Systems

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 外泌体诊断与治疗市场 2029：提供新机会的国家
• 外泌体诊断与治疗市场 2029：提供新机会的细分市场
• 外泌体诊断与治疗市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.47 billion in 2024 to $0.61 billion in 2025 at a compound annual growth rate (CAGR) of 30.1%. The growth in the historic period can be attributed to biological research advancements, the emergence of precision medicine, biomedical imaging innovations, cancer research and oncology, and healthcare industry investments

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to growing clinical applications, integration with digital health technologies, supportive regulatory environment, gene editing and RNA therapeutics, and expanded role in immuno-oncology. Major trends in the forecast period include exosome-based drug discovery, biomimetic exosome engineering, commercialization of exosome products, exosome-loaded therapeutic cargo, and liquid biopsy for cancer screening.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

The upward trajectory of the exosome diagnostic and therapeutic market is further fueled by the increasing size of the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older, often in the later stages of life. This demographic expansion contributes significantly to the demand for exosome diagnostics and therapeutics, as exosomes serve as valuable tools for diagnosing and addressing age-related conditions. Notably, a report from the World Health Organization (WHO) in October 2022 indicates a profound demographic shift, with one in six individuals projected to be 60 or older by 2030 globally. By 2050, an estimated 2.1 billion people worldwide will be 60 years old or older. This demographic shift underscores the substantial impact of the rising geriatric population on driving the growth of the exosome diagnostic and therapeutic market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

Major players in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. A noteworthy example is the collaboration between Cytiva, a prominent US-based biotechnology company, and RoosterBio Inc., also a US-based biotechnology company. Announced in October 2023, this partnership aims to improve the exosome purification process, a current bottleneck hindering the widespread adoption of promising gene therapies and other innovative modalities. By combining the strengths of both entities, the collaboration seeks to address a significant challenge limiting the use of exosomes in therapeutic applications, particularly as carriers for gene therapies and biologics. The envisioned outcome is the advancement of large-scale manufacturing capabilities for exosomes.

In June 2023, Evox Therapeutics Ltd., a biotechnology company based in the UK, acquired the engEx-AAV technology platform from Codiak Biosciences for an undisclosed sum. The purpose of this acquisition is to utilize the engEx-AAV technology to improve exosome-mediated delivery systems, facilitating the advancement of innovative gene therapies and genome editors. This strategic decision aims to bolster Evox Therapeutics' capabilities in developing effective genetic medicines. Codiak Biosciences is a biopharmaceutical company located in the US that focuses on creating exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market include Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Instruments; Software; Reagents And Kits
• 2) By Application: Diagnostics; Therapeutic
• 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
• Subsegments:
• 1) By Instruments: Exosome Isolation Systems; Characterization Instruments; Analysis Devices
• 2) By Software: Data Analysis Software; Exosome Profiling Software; Laboratory Management Software
• 3) By Reagents And KITS: Isolation KITS; Characterization Reagents; Assay KITS
• Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Diagnostic And Therapeutic Market Characteristics

3. Exosome Diagnostic And Therapeutic Market Trends And Strategies

4. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Exosome Diagnostic And Therapeutic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Exosome Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Exosome Diagnostic And Therapeutic Market Growth Rate Analysis
• 5.4. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Exosome Diagnostic And Therapeutic Total Addressable Market (TAM)

6. Exosome Diagnostic And Therapeutic Market Segmentation

• 6.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Software
• Reagents And Kits
• 6.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Therapeutic
• 6.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Hospitals And Clinics
• Other End Users
• 6.4. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exosome Isolation Systems
• Characterization Instruments
• Analysis Devices
• 6.5. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Exosome Profiling Software
• Laboratory Management Software
• 6.6. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Reagents And KITS, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolation KITS
• Characterization Reagents
• Assay KITS

7. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

• 7.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Diagnostic And Therapeutic Market

• 8.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Diagnostic And Therapeutic Market

• 9.1. China Exosome Diagnostic And Therapeutic Market Overview
• 9.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Diagnostic And Therapeutic Market

• 10.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Diagnostic And Therapeutic Market

• 11.1. Japan Exosome Diagnostic And Therapeutic Market Overview
• 11.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Diagnostic And Therapeutic Market

• 12.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Diagnostic And Therapeutic Market

• 13.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Diagnostic And Therapeutic Market

• 14.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
• 14.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Diagnostic And Therapeutic Market

• 15.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
• 15.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Diagnostic And Therapeutic Market

• 16.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Diagnostic And Therapeutic Market

• 17.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Diagnostic And Therapeutic Market

• 18.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Diagnostic And Therapeutic Market

• 19.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Diagnostic And Therapeutic Market

• 20.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Diagnostic And Therapeutic Market

• 21.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
• 21.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Diagnostic And Therapeutic Market

• 22.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Diagnostic And Therapeutic Market

• 23.1. North America Exosome Diagnostic And Therapeutic Market Overview
• 23.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Diagnostic And Therapeutic Market

• 24.1. USA Exosome Diagnostic And Therapeutic Market Overview
• 24.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Diagnostic And Therapeutic Market

• 25.1. Canada Exosome Diagnostic And Therapeutic Market Overview
• 25.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Diagnostic And Therapeutic Market

• 26.1. South America Exosome Diagnostic And Therapeutic Market Overview
• 26.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Diagnostic And Therapeutic Market

• 27.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Diagnostic And Therapeutic Market

• 28.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
• 28.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Diagnostic And Therapeutic Market

• 29.1. Africa Exosome Diagnostic And Therapeutic Market Overview
• 29.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

• 30.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape
• 30.2. Exosome Diagnostic And Therapeutic Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Techne Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

• 31.1. BioVision Inc.
• 31.2. System Biosciences LLC
• 31.3. Evox Therapeutics Ltd.
• 31.4. ExCoBio Inc.
• 31.5. BioCat GmbH
• 31.6. NanoSomix Inc.
• 31.7. Exosome Diagnostics Inc.
• 31.8. Capricor Therapeutics Inc.
• 31.9. Aethlon Medical Inc.
• 31.10. Codiak BioSciences Inc.
• 31.11. NX Pharmagen Inc.
• 31.12. Exiqon A/S
• 31.13. Aegle Therapeutics Corporation
• 31.14. AMS Biotechnology Ltd.
• 31.15. Cell Guidance Systems

32. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

34. Recent Developments In The Exosome Diagnostic And Therapeutic Market

35. Exosome Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

• 35.1 Exosome Diagnostic And Therapeutic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Exosome Diagnostic And Therapeutic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Exosome Diagnostic And Therapeutic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer